The elevated ROS production in gastric cancer can initiate genotoxic consequences, contributing to genetic instability, DNA damage, metabolic adaptation, drug resistance and occasional cell death
The current research, while promising, highlights a critical translational gap between preclinical findings and consistent human outcomes
Experts speaking with Nutrition Insight have described the compound as operating in a "gray zone between medicine, wellness, and illicit markets," with users ranging from teenagers to people in their seventies
2 , chi-squared
Novo Nordisk, maker of Wegovy, and Eli Lilly, maker of Zepbound, both launched direct-to-consumer telehealth platforms to streamline access
Induratio penis plastica: effectivity of low-dose radiotherapy at different clinical stages